Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of ethynyl alanine amino diol compounds to inhibit enzymatic conversion of angiotensinogen to angiotensin I

Use of ethynyl alanine amino diol compounds to inhibit enzymatic conversion of angiotensinogen to angiotensin I

US Patent 6515025 · Granted Feb 4, 2003

Estimated economic value: $84,871,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Bicyclic peptide oligonucleotide conjugates2025
Exon skipping oligomer conjugates for muscular dystrophy2025
Chimeric peptides for antisense delivery2025
Upright gluteus exercise machine2025
Peptide oligonucleotide conjugates2025
Trimeric peptides for antisense delivery2024
Cell-penetrating peptides for antisense delivery2024
Modified antisense oligomers for exon inclusion in spinal muscular atrophy2024
Peptide oligonucleotide conjugates2023
Peptide oligonucleotide conjugates2023
Oligonucleotides for treating expanded repeat diseases2023
Exon skipping oligomer conjugates for muscular dystrophy2023